Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S5AL
|
||||
| Former ID |
DCL001040
|
||||
| Drug Name |
XTL-2125
|
||||
| Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Discontinued in Phase 1 | [536646] | ||
| Company |
XTL Biopharmaceutical
|
||||
| Target and Pathway | |||||
| Target(s) | RNA polymerase | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

